Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Capital Leases: 2009-2015

Historic Capital Leases for Avadel Pharmaceuticals (AVDL) over the last 6 years, with Mar 2015 value amounting to $9,000.

  • Avadel Pharmaceuticals' Capital Leases fell 92.50% to $9,000 in Q1 2015 from the same period last year, while for Mar 2015 it was $9,000, marking a year-over-year decrease of 92.50%. This contributed to the annual value of $15,000 for FY2013, which is 91.62% down from last year.
  • Avadel Pharmaceuticals' Capital Leases amounted to $9,000 in Q1 2015, which was down 75.00% from $36,000 recorded in Q3 2014.
  • Over the past 5 years, Avadel Pharmaceuticals' Capital Leases peaked at $335,000 during Q2 2011, and registered a low of $9,000 during Q1 2015.
  • Its 3-year average for Capital Leases is $83,125, with a median of $95,000 in 2014.
  • Its Capital Leases has fluctuated over the past 5 years, first surged by 702.86% in 2011, then crashed by 92.50% in 2015.
  • Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Capital Leases stood at $251,000 in 2011, then fell by 28.69% to $179,000 in 2012, then crashed by 91.62% to $15,000 in 2013, then slumped by 70.49% to $36,000 in 2014, then slumped by 92.50% to $9,000 in 2015.
  • Its Capital Leases stands at $9,000 for Q1 2015, versus $36,000 for Q3 2014 and $70,000 for Q2 2014.